Our Services
Medical Information
Helpful Resources
Published on: 5/22/2026
Intranasal and short-course systemic corticosteroids are scientifically proven to reduce nasal polyp size and improve symptoms while carrying a low risk when used at the correct dose and duration. Patient education on dosing, spray technique, and monitoring is key to overcoming fears about tissue damage or systemic side effects.
There are several factors to consider regarding administration methods, side-effect mitigation, and alternative therapies so see below for the complete details to guide your next healthcare steps.
Chronic nasal polyps are benign growths inside the nose or sinuses that can cause congestion, loss of smell, facial pressure, and breathing difficulty. Corticosteroids—both topical and systemic—remain the cornerstone of medical therapy, reducing inflammation and shrinking polyp size. Yet many patients delay or avoid steroid use due to steroid phobia in treating chronic nasal polyps growth. This article reviews the science, addresses common fears, and offers practical strategies to help you make informed decisions.
• Noncancerous, fluid-filled mucosal swellings
• Often associated with chronic rhinosinusitis, asthma or aspirin sensitivity
• Symptoms include nasal blockage, runny nose, reduced smell, facial pain
• Untreated, they can recur after surgery and impair quality of life
Corticosteroids reduce the inflammation driving polyp formation. Two main types are used:
Intranasal Corticosteroids (INCS)
Systemic Corticosteroids
Numerous clinical trials show INCS reduce polyp size and improve symptoms in 60–80% of patients. Short courses of systemic steroids often produce dramatic relief, though benefits can wane unless paired with INCS or other maintenance strategies.
Steroid phobia in treating chronic nasal polyps growth stems from concerns about side effects, both real and perceived. Common fears include:
• "Steroids will thin my nose tissue or cause nosebleeds."
• "Oral steroids will weaken my bones, increase blood sugar, or harm my heart."
• "Long-term steroid use is addictive or suppresses my immune system."
While corticosteroids do carry risks, the dose, route, and duration strongly influence safety. Education helps balance proven benefits against manageable risks.
Benefits
Risks
Mitigation
Benefits
Risks (mostly dose- and duration-related)
Mitigation
Key takeaway: For most patients, the benefits of steroids—especially intranasal—outweigh the relatively low risk when used correctly.
Patient Education
Start with Intranasal Therapy
Use the Lowest Effective Dose
Practice Proper Administration
Combine With Saline Irrigation
Monitor for Side Effects
Explore Alternative Therapies When Appropriate
Shared Decision-Making
If you're experiencing nasal congestion, facial pressure, or loss of smell and want to understand your symptoms better before seeing a specialist, try Ubie's free AI-powered Medically Approved LLM Symptom Checker Chat Bot to receive personalized insights about your condition and guidance on whether you should seek care for potential nasal polyps.
While most nasal polyp issues aren't life-threatening, contact your doctor right away if you experience:
Always speak to a doctor about any symptom that could signal a more serious condition, especially before starting or stopping steroids.
By understanding the solid science behind steroid use, you can overcome fears, optimize your treatment plan, and reduce the likelihood of polyp recurrence. Talk openly with your healthcare provider to tailor a strategy that meets your needs and helps you breathe easier.
(References)
* Kalish LH, et al. Topical and Systemic Corticosteroids for Chronic Rhinosinusitis with Nasal Polyps: Review. Laryngoscope. 2021 Jul;131(7):1443-1452. PMID: 33666276.
* Parikh A, et al. Long-term safety of mometasone furoate nasal spray for the treatment of chronic rhinosinusitis with nasal polyps. Rhinology. 2012 Sep;50(3):284-90. PMID: 22894089.
* Jang DW, et al. Topical Corticosteroids for Chronic Rhinosinusitis with Nasal Polyps: A Systematic Review and Meta-analysis. Otolaryngol Head Neck Surg. 2017 Jan;156(1):16-25. PMID: 27729519.
* Mandl M, et al. Pharmacokinetics and Pharmacodynamics of Intranasal Corticosteroids. Clin Rev Allergy Immunol. 2017 Apr;52(2):189-198. PMID: 27076229.
* Smith KJ, et al. Adherence to topical corticosteroid therapy in chronic rhinosinusitis with nasal polyps. Am J Rhinol Allergy. 2020 Jan;34(1):92-98. PMID: 31533501.
We would love to help them too.
For First Time Users
We provide a database of explanations from real doctors on a range of medical topics. Get started by exploring our library of questions and topics you want to learn more about.
Was this page helpful?
Purpose and positioning of servicesUbie Doctor's Note is a service for informational purposes. The provision of information by physicians, medical professionals, etc. is not a medical treatment. If medical treatment is required, please consult your doctor or medical institution. We strive to provide reliable and accurate information, but we do not guarantee the completeness of the content. If you find any errors in the information, please contact us.